myocardial infarction

Myocardial infarction research reveals immune-driven cardiac damage. Learn how targeting NK cells could improve heart recovery. The New England Journal of Medicine: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

Context Explanation

Psychiatry Advisor: Digital Cognitive Therapy Can Reduce Cardiac Anxiety After Myocardial Infarction Tofacitinib shows safety comparable with biologics for PsA regarding serious infections, myocardial infarction or stroke, and malignancy but is tied to a higher risk for VTE than TNF inhibitors. The New England Journal of Medicine: Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ... Medscape: Costs of Treatment of Acute Myocardial Infarction in Canadian and US Hospitals Costs of Treatment of Acute Myocardial Infarction in Canadian and US Hospitals